MoneyWorks4Me

Everest Organics - Quaterly Results

09 Feb 2024 Evaluate
The revenue for the December 2023 quarter is pegged at Rs. 525.07 millions, about 21.28% up against Rs. 432.94 millions recorded during the year-ago period.Net Profit for the quarter ended December 2023 dipped to Rs. 0.18  millions from Rs. 15.20 millions  in the corresponding previous quarter.A decline of 29.30 millions was observed in the OP in the quarter ended December 2023 from 31.59 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 525.07 432.94 21.28 1446.25 1322.94 9.32 1830.48 2000.47 -8.50
Other Income 1.30 56.49 -97.70 5.89 62.54 -90.58 69.44 22.11 214.07
PBIDT 29.30 31.59 -7.25 86.16 49.03 75.73 78.74 86.39 -8.86
Interest 14.47 8.14 77.76 42.24 23.57 79.21 33.10 31.03 6.67
PBDT 14.83 23.45 -36.76 43.92 25.46 72.51 45.64 55.36 -17.56
Depreciation 13.30 10.98 21.13 39.44 32.15 22.67 44.74 37.97 17.83
PBT 1.53 12.47 -87.73 4.48 -6.69 -166.97 0.90 17.39 -94.82
TAX 1.35 -2.73 -149.45 3.67 -3.73 -198.39 2.72 5.96 -54.36
Deferred Tax 1.15 -2.73 -142.12 2.97 -3.73 -179.62 2.57 3.06 -16.01
PAT 0.18 15.20 -98.82 0.81 -2.96 -127.36 -1.82 11.43 -115.92
Equity 80.00 80.00 0.00 80.00 80.00 0.00 80.00 80.00 0.00
PBIDTM(%) 5.58 7.30 -23.52 5.96 3.71 60.75 4.30 4.32 -0.39
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..